ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ATRA Atara Biotherapeutics Inc

0.7147
-0.0039 (-0.54%)
After Hours
Last Updated: 08:37:02
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Atara Biotherapeutics Inc ATRA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0039 -0.54% 0.7147 08:37:02
Open Price Low Price High Price Close Price Previous Close
0.7211 0.69 0.7366 0.7147 0.7186
more quote information »

Recent News

Date Time Source Heading
06/4/202407:01BWAtara Biotherapeutics, Inc. Reports Inducement Grant Under..
28/3/202423:30BWAtara Biotherapeutics Announces Fourth Quarter and Full Year..
07/3/202410:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202410:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202412:21EDGAR2Form 144 - Report of proposed sale of securities
05/3/202412:19EDGAR2Form 144 - Report of proposed sale of securities
05/3/202412:18EDGAR2Form 144 - Report of proposed sale of securities
05/3/202412:17EDGAR2Form 144 - Report of proposed sale of securities
01/3/202401:05BWAtara Biotherapeutics Receives FDA Clearance of IND..
29/2/202408:30BWAtara Biotherapeutics to Participate in Cell Therapy Panel..
24/2/202408:30EDGAR2Form 8-K - Current report
15/2/202401:00BWAtara Biotherapeutics Announces Submission of..
01/2/202418:25PRNUSAtara Biotherapeutics and Pierre Fabre Laboratories Announce..
01/2/202410:30BWAtara Biotherapeutics and Pierre Fabre Laboratories Announce..
10/1/202408:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202408:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202408:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202408:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202408:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202408:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/1/202408:01EDGAR2Form 8-K - Current report
09/1/202401:00BWAtara Biotherapeutics Announces $15 Million Registered..
09/1/202400:11EDGAR2Form 8-K - Current report
09/1/202400:00BWAtara Biotherapeutics to Present Recent Progress and Key..
05/1/202408:01BWAtara Biotherapeutics to Present at the 42nd Annual J.P...
04/1/202408:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/12/202308:30EDGAR2Form 8-K - Current report
21/12/202308:01BWAtara Biotherapeutics Announces Closing of Expanded Global..
12/12/202304:00BWAtara Biotherapeutics Presents Positive Preclinical Data on..
02/12/202308:01BWAtara Biotherapeutics, Inc. Reports Inducement Grants Under..
30/11/202310:05BWAtara Biotherapeutics To Present Positive New Tab-cel®..
23/11/202308:01BWAtara Biotherapeutics to Participate at the 6th Annual..
21/11/202309:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202309:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202309:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202309:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202309:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202309:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202308:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/11/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
11/11/202308:01BWAtara Biotherapeutics To Participate at the Stifel..
09/11/202309:35BWAtara Biotherapeutics Announces Primary Analysis Data from..
02/11/202308:25EDGAR2Form S-3 - Registration statement under Securities Act of..
02/11/202307:05EDGAR2Form 8-K - Current report
01/11/202323:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202323:35EDGAR2Form 8-K - Current report
01/11/202323:30BWAtara Biotherapeutics Announces Expanded Global Tab-cel®..
07/10/202307:01BWAtara Biotherapeutics, Inc. Reports Inducement Grants Under..
20/9/202306:50DJNAtara Biotherapeutics to Submit New FDA Biologics License..
20/9/202306:01BWAtara Biotherapeutics Announces Plans to Submit Tab-cel® BLA..

Your Recent History

Delayed Upgrade Clock